TheEdgeResearch
Home / Stocks / PRXTF

Pure Extracts Technologies Corp. (PRXTF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.01 ▼ -12.90%
Market Cap
$885,394
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.17
52-Wk Range
0.0054-0.0062
CEO
Ben Nikolaevsky
Country
CA
Currency
USD

Pure Extracts Technologies Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Pemberton, BC, CA. The stock last traded at $0.01, down 12.90% on the session, giving a market capitalisation of $885,394. On trailing twelve-month figures it carries a trailing P/E of -0.19, a net margin of -426.5%. Its beta of 2.17 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.19
Price / Sales
1.29
Price / Book
0.40
EV / EBITDA
-0.77
Gross margin
-215.7%
Operating margin
-396.7%
Net margin
-426.5%
Return on equity
Debt / equity
0.76
Current ratio
0.69
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
IPO date
2021-01-08
Headquarters
Pemberton, BC, CA
About Pure Extracts Technologies Corp.

Headquartered in Pemberton, Canada, Pure Extracts Technologies Corp. focuses on the extraction and processing of cannabis, hemp, and functional mushrooms. The company's primary offerings include a range of oils, specifically those derived from THC and CBD, as well as various other related derivative products. Additionally, Pure Extracts Technologies is actively engaged in developing and commercializing wellness products from functional mushrooms and medical products utilizing psychedelics. The company assumed its present name in October 2020, having previously been known as Big Sky Petroleum Corporation.

Comparable companies

Pure Extracts Technologies Corp. is most often compared with the following Healthcare names:

ETRGFGNOWLTTSFNBGVPCNTSBUDFSEPSFSLGWFSPLIFSUVZ
More research on PRXTF
PRXTF technical analysis PRXTF TheEdge Score Compare against peers
Open full interactive analysis & DCF →